Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 120 of 120 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/01/24
End: 03/01/29
Due: 03/01/30
Phase: N/A
Priority: Normal
Start: 03/03/22
End: 06/01/24
Due: 06/01/25
Phase: N/A
Priority: Normal
Start: 08/31/25
End: 07/31/26
Due: 07/31/27
Phase: N/A
Priority: Normal
Start: 09/04/24
End: 08/13/26
Due: 08/13/27
To Evaluate the Efficacy of Diquafosol Sodium in the Treatment of MGD in Different Treatment Pattern
Phase: N/A
Priority: Normal
Start: 08/05/22
End: 05/20/25
Due: 05/20/26
Phase: N/A
Priority: Normal
Start: 12/09/24
End: 11/30/25
Due: 11/30/26
Phase: N/A
Priority: Normal
Start: 02/28/22
End: 07/31/22
Due: 07/31/23
Phase: N/A
Priority: Normal
Start: 09/01/20
End: 08/30/21
Due: 08/30/22
Phase: N/A
Priority: Normal
Start: 07/03/24
End: 12/30/26
Due: 12/30/27
Phase: N/A
Priority: Normal
Start: 12/13/19
End: 12/31/49
Due: 12/31/50
Phase: N/A
Priority: Normal
Start: 03/01/22
End: 12/30/26
Due: 12/30/27
Phase: N/A
Priority: Normal
Start: 05/14/18
End: 05/31/21
Due: 05/31/22
Phase: N/A
Priority: Normal
Start: 06/16/20
End: 08/31/24
Due: 08/31/25
Phase: N/A
Priority: Normal
Start: 02/20/23
End: 03/31/26
Due: 03/31/27
Phase: N/A
Priority: Normal
Start: 03/23/23
End: 04/22/24
Due: 04/22/25
Phase: N/A
Priority: Normal
Start: 10/28/24
End: 04/30/27
Due: 04/30/28
Phase: N/A
Priority: Normal
Start: 04/30/15
End: 07/31/18
Due: 07/31/19
Phase: N/A
Priority: Normal
Start: 11/01/22
End: 10/31/27
Due: 10/31/28
Phase: N/A
Priority: Normal
Start: 12/05/22
End: 12/31/27
Due: 12/31/28
Phase: N/A
Priority: Normal
Start: 03/14/21
End: 06/30/22
Due: 06/30/23